Company Description
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States.
The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants.
It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions.
The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
| Country | United States |
| Founded | 1997 |
| IPO Date | Sep 21, 2004 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Robert Banks |
Contact Details
Address: 380 Lackawanna Place South Orange, New Jersey 07079 United States | |
| Phone | 201 343 5202 |
| Website | nephros.com |
Stock Details
| Ticker Symbol | NEPH |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001196298 |
| CUSIP Number | 640671400 |
| ISIN Number | US6406714005 |
| Employer ID | 13-3971809 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert Banks | President, Chief Executive Officer and Director |
| Judy F. Krandel C.F.A. | Chief Financial Officer |
| Brianne McGuire | Director of Brand, Marketing and Business Development |
| Vashone R. Thomas | Vice President of Quality, Regulatory, and Human Resources |
| Greg Lucas | President of Aether Water Systems |
| Judy Mazzini | Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 16, 2025 | 8-K | Current Report |
| May 15, 2025 | 10-Q | Quarterly Report |
| May 8, 2025 | 8-K | Current Report |
| Apr 30, 2025 | ARS | Filing |
| Apr 30, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 30, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 28, 2025 | 8-K | Current Report |
| Apr 1, 2025 | 8-K | Current Report |
| Mar 24, 2025 | 10-K | Annual Report |
| Mar 6, 2025 | 8-K | Current Report |